朗瑪信息(300288.SZ):2024年第一季度業績下滑主要是由於兩大主要業務醫療信息服務及移動轉售業務收入減少導致
格隆匯4月24日丨朗瑪信息(300288.SZ)在投資者互動平台表示,公司經營正常,2024年第一季度業績下滑主要是由於兩大主要業務醫療信息服務及移動轉售業務收入減少導致,其中全資子公司廣州啟生信息技術有限公司(39健康網)運營的醫療信息服務業務收入下降主要是由於啟生信息的大量優質醫療信息內容沒有用於銷售變現而是用於自身醫療人工智能的學習和訓練,同時研發費用增加導致;控股子公司貴陽朗瑪通信科技有限公司運營的移動轉售業務收入下降主要是由於年初運營商對移動轉售業務的限制導致一季度業務沒能正常開展,但從本月起,朗瑪通信移動轉售業務已恢復正常,並且從3月底開始,增加了與中國聯通的移動轉售業務合作。目前公司醫學人工智能研發進展順利,後續會把人工智能技術賦能到公司各業務線的發展,公司亦在繼續加強各業務板塊的聯動和資源共享。公司經營穩定,現金流充裕。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.